N-[5-(4-Pyridinylmethyl)thiazol-2-yl]cyclohexanecarboxamide

ID: ALA4228352

Chembl Id: CHEMBL4228352

PubChem CID: 145968189

Max Phase: Preclinical

Molecular Formula: C16H19N3OS

Molecular Weight: 301.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ncc(Cc2ccncc2)s1)C1CCCCC1

Standard InChI:  InChI=1S/C16H19N3OS/c20-15(13-4-2-1-3-5-13)19-16-18-11-14(21-16)10-12-6-8-17-9-7-12/h6-9,11,13H,1-5,10H2,(H,18,19,20)

Standard InChI Key:  DKFYYIJYLYWBEB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4228352

    ---

Associated Targets(non-human)

Histoplasma capsulatum (403 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P388D1 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 301.42Molecular Weight (Monoisotopic): 301.1249AlogP: 3.65#Rotatable Bonds: 4
Polar Surface Area: 54.88Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 8.01CX Basic pKa: 5.07CX LogP: 3.67CX LogD: 3.58
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.94Np Likeness Score: -1.91

References

1. Ishita K, Stefanopoulos S, Khalil A, Cheng X, Tjarks W, Rappleye CA..  (2018)  Synthesis and biological evaluation of aminothiazoles against Histoplasma capsulatum and Cryptococcus neoformans.,  26  (9): [PMID:29580849] [10.1016/j.bmc.2018.01.024]

Source